1. Screening Libraries
  2. Kinase Inhibitor Library

Kinase Inhibitor Library

Cat. No.: HY-L009
Library Contents: XLSX PDF

A unique collection of 764 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

sales@MedChemExpress.cn

Top Publications Citing Use of Products

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 764 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

•   The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).

•   Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Rich documentation with structure, IC50, and customer reviews.

•   NMR and HPLC validated to ensure high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 764 kinase inhibitors/regulators supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Kinase Inhibitor Library

Source: MedChem Express

Contents of Kinase Inhibitor Library

Plate layout: HY-L009-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty 3-Methyladenine 5-Aminosalicylic acid 2-Deoxy-D-glucose Metformin (hydrochloride) 3-Bromopyruvic acid Poloxime AG 18 Scopoletin MNS 4μ8C Empty
b Empty Trapidil AG126 CID755673 SP600125 RIPA-56 TDZD-8 SC-514 Resveratrol NSC95682 SU5416 Empty
c Empty Danthron SU9516 Phenformin (hydrochloride) CGP 57380 Piceatannol IQ-1S (free acid) NU2058 Y-27632 PHA-767491 (hydrochloride) kb NB 142-70 Empty
d Empty TPI-1 Chrysophanol BMS-345541 (free base) Bakuchiol AS-605240 AICAR Necrostatin-1 SMI-16a Anisomycin RG13022 Empty
e Empty Honokiol PD98059 Formononetin Apigenin Genistein Emodin SAR245409 Butein LY-364947 Bikinin Empty
f Empty TCS-PIM-1-4a RG14620 GW 441756 TC-DAPK 6 SC66 Indirubin-3'-monoxime HA-100 TPCA-1 NU 7026 Compound 401 Empty
g Empty PP1 BX517 Y15 Wogonin Dihydroartemisinin PF-06651600 Scutellarein A 77-01 RepSox Zoledronic acid (monohydrate) Empty
h Empty BMS-345541 CHR-6494 IRAK inhibitor 1 AG-490 Tanshinone IIA [6]-Gingerol SU 5402 JANEX-1 Poloxin SKF-86002 Empty

Plate layout: HY-L009-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty ID-8 Amlexanox Hispidulin Salidroside Nocodazole PP2 Quercetin SKI II MCB-613 AG1024 Empty
b Empty AS-252424 PF-06447475 Tyrphostin AG 528 IRAK inhibitor 2 Ruxolitinib LY294002 Hydroxyfasudil Fingolimod AR-A014418 PP 242 Empty
c Empty LY3177833 INK-128 TSU-68 IC261 Thiazovivin AT13148 STO-609 AG-1478 Isorhamnetin Tyrphostin AG 879 Empty
d Empty STF-083010 1-Naphthyl PP1 TWS119 PP121 Vps34-PIK-III Dihydromyricetin Y-27632 (dihydrochloride) Triciribine Lonidamine AG 555 Empty
e Empty PS-1145 Bupivacaine (hydrochloride) XL413 (hydrochloride) RKI-1447 Peficitinib Kenpaullone FR 180204 Fasudil (Hydrochloride) PD158780 TTP 22 Empty
f Empty SB 202190 1-NM-PP1 APY29 KW-2449 TCS JNK 5a Oglufanide GSK1059615 ZM 306416 GDC-0879 Tideglusib Empty
g Empty SL327 ML167 SB-505124 Dicoumarol DPH CC-115 AT7867 LM22A-4 Pim1/AKK1-IN-1 NVP-BVU972 Empty
h Empty PRT-060318 MSC2530818 PF-06409577 PQ401 SB 525334 Fingolimod (hydrochloride) ETC-1002 BMS-265246 SSR128129E TG100-115 Empty

Plate layout: HY-L009-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty NG 52 L-779450 PI-103 Ingenol AZD-1480 CP-466722 SRPIN340 CX-4945 IPA-3 TA-01 Empty
b Empty Ro-3306 K02288 BQR-695 ML347 SD-208 1-Naphthyl PP1 (hydrochloride) VS-5584 Roscovitine TPX-0005 Tetrahydropalmatine Empty
c Empty ISCK03 Coptisine (chloride) CGP60474 BIO WP1066 AICAR (phosphate) CH5183284 R1530 TAS-301 SAR131675 Empty
d Empty SGX-523 SB 415286 LFM-A13 PD153035 PD 169316 A-769662 TCS 359 PF06650833 PHA-793887 ZLN024 (hydrochloride) Empty
e Empty AZD-7762 MLN1117 R-268712 BML-277 EMD638683 CZC24832 TGX-221 SC79 GSK180736A GW2580 Empty
f Empty MLN120B TCS PIM-1 1 APTO-253 Sanguinarine (chloride) ZM39923 (hydrochloride) LJI308 SB 239063 VE-821 PD168393 Tivantinib Empty
g Empty LY2157299 Brivanib MSDC 0160 LDC000067 SB 216763 Baricitinib AIM-100 SU6656 AZD-5438 CX-4945 (sodium salt) Empty
h Empty PF-04217903 Tetrahydrocurcumin SB1317 CC-115 (hydrochloride) Src Inhibitor 1 Motesanib GNF-2 CRT0066101 dihydrochloride Linifanib ENMD-2076 Empty

Plate layout: HY-L009-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty WHI-P154 JNJ-38877605 IM-12 CH5132799 SB 203580 HG-10-102-01 Ro 28-1675 CCT245737 BI-78D3 MLi-2 Empty
b Empty AZD1208 PF-4989216 DMH-1 ZINC00881524 SNS-032 BS-181 TAK-659 (hydrochloride) CL-387785 LJH685 AT9283 Empty
c Empty PLX647 GDC-0326 GSK 650394 EAI045 Losmapimod GSK'872 IMD-0354 Chelerythrine Chloride WP1130 SB-431542 Empty
d Empty PI-103 (Hydrochloride) SNS-062 K145 (hydrochloride) AMG319 Acumapimod TIC10 MHY1485 APS-2-79 BIBX 1382 Purvalanol A Empty
e Empty T56-LIMKi ZM 336372 Solcitinib PIK-93 PF-4708671 BI-D1870 5-Iodotubercidin Dovitinib Fruquintinib Erlotinib Empty
f Empty Reversine A66 IRAK-1-4 Inhibitor I KU-55933 Tanshinone IIA sulfonate (sodium) PD-166866 Toceranib IRAK inhibitor 6 Dinaciclib CID 2011756 Empty
g Empty IC-87114 CC-223 D4476 GSK583 Sunitinib BLZ945 GSK2578215A EW-7197 TAK-715 CVT-313 Empty
h Empty ACHP (Hydrochloride) Acalisib WEHI-345 Flavopiridol Dehydrocorydaline (chloride) VX-702 Ruxolitinib (phosphate) NVP-ACC789 SGI-1776 PF-06463922 Empty

Plate layout: HY-L009-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Palomid 529 OSI-027 LY3023414 LDN-212854 ANA-12 AZD 6482 SR-3677 PHT-427 Telatinib PF-670462 Empty
b Empty NVP-BKM120 AT7867 (dihydrochloride) PQR309 GS-9973 ZM323881 (hydrochloride) BAY-1895344 (hydrochloride) NT157 INCB28060 BIX02188 AZ20 Empty
c Empty AZD6738 APY0201 KU-57788 PLX-4720 SB 203580 (hydrochloride) AXL1717 CYT387 LTURM34 GNE-317 GSK2256098 Empty
d Empty CAL-101 ITD-1 Tomatidine GSK2656157 KRN-633 JH-II-127 Duvelisib (R enantiomer) Duvelisib ZSTK474 CP-673451 Empty
e Empty Pexidartinib GNF-5 TP-3654 AT7519 (Hydrochloride) LDN-214117 Vatalanib (dihydrochloride) CHIR-124 Linsitinib URMC-099 HS-173 Empty
f Empty CHZ868 AVL-292 AM-2394 NVP-BAW2881 HMN-214 LY3009120 CC-401 (hydrochloride) PF-04691502 GW788388 GSK-690693 Empty
g Empty GLPG0634 Vps34-IN-1 U0126 Lenvatinib Afuresertib Icotinib (Hydrochloride) Wortmannin LOXO-101 AZD5363 GSK2141795 Empty
h Empty BMS-3 AZ191 ON123300 Erlotinib (Hydrochloride) PRT062607 (Hydrochloride) AS703026 BMS-5 MK-8745 GSK429286A Torin 2 Empty

Plate layout: HY-L009-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BMS-911543 LDC4297 Purvalanol B VRT752271 GSK2636771 CUDC-101 LEE011 TBB LY3200882 VX-745 Empty
b Empty LY2603618 Pazopanib XL228 Flavopiridol (Hydrochloride) Sotrastaurin S49076 Ginkgolide C PCI-32765 BIX02189 UNC2250 Empty
c Empty AEE788 MEK162 Brivanib (alaninate) BYL-719 SU14813 Go 6983 AZM475271 PD173955 GNE-7915 OSI-930 Empty
d Empty Crenolanib SAR405 LY2874455 SAR-20347 Cerdulatinib PF-04979064 Erdafitinib NVP-BKM120 (Hydrochloride) Gefitinib AZD2932 Empty
e Empty Amuvatinib Quercitrin PI3K inhibitor X AZD-3463 Crizotinib Cediranib ISRIB (trans-isomer) GSK2606414 AZ 628 SUN11602 Empty
f Empty SLx-2119 AZ3146 GDC-0349 Oclacitinib (maleate) AZD2858 SB-590885 ONO-4059 Tivozanib WHI-P97 SGI-7079 Empty
g Empty GDC-0623 BRAF inhibitor ONO-4059 (analog) AZD8186 AS 602801 Selumetinib GDC-0068 LSKL, Inhibitor of Thrombospondin (TSP-1) AZD3759 NVP-LCQ195 Empty
h Empty GDC-0032 PHA-848125 AZD8330 Necrosulfonamide BMS-754807 AZD0156 Perifosine MK-5108 CX-6258 Scutellarin Empty

Plate layout: HY-L009-7

1 2 3 4 5 6 7 8 9 10 11 12
a Empty AZD2014 CEP-33779 GSK2334470 BAY 61-3606 (dihydrochloride) AMG-337 VE-822 AZD4547 UNC2881 Afuresertib (hydrochloride) BI-847325 Empty
b Empty Tozasertib MRT67307 Sorafenib CHIR-99021 Acalabrutinib KU-0063794 AZD-8055 JI-101 YM-201636 Pelitinib Empty
c Empty Mubritinib PF-04217903 (methanesulfonate) HTH-01-015 BMS-794833 NVP-TAE 226 Baricitinib (phosphate) Ki8751 CP-724714 AZD-8835 Dacomitinib Empty
d Empty LY2784544 R406 (free base) ETP-46464 MRT68921 (hydrochloride) BX-912 Ro 5126766 Dorsomorphin (dihydrochloride) Rigosertib (sodium) Sapitinib Pazopanib (Hydrochloride) Empty
e Empty PF-03814735 XMD8-92 Danusertib Vandetanib UNC2025 DMAT MLN8054 GW843682X CI-1040 AZD7545 Empty
f Empty B-Raf inhibitor 1 CCT241533 (hydrochloride) SBE13 (Hydrochloride) NVS-PAK1-1 BMS-536924 MK 2206 (dihydrochloride) Irbinitinib Mps1-IN-2 M3814 PD0325901 Empty
g Empty Dovitinib (lactate) CH5424802 Regorafenib IKK 16 Palbociclib (hydrochloride) LY2409881 AZ-5104 Afatinib CHIR-98014 Olmutinib Empty
h Empty Crizotinib (hydrochloride) Dasatinib Bucladesine (calcium salt) CZC-25146 PIK-75 DCC-2618 PIK-294 Vemurafenib PF-3758309 ONO-4059 (hydrochloride) Empty

Plate layout: HY-L009-8

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Poziotinib Bucladesine (sodium salt) PF-573228 EMD-1214063 Apatinib Imatinib Toceranib (phosphate) WZ4002 WYE-354 AT7519 (trifluoroacetate) Empty
b Empty WZ4003 CCT129202 GDC-0980 Masitinib CNX-774 CDK9-IN-1 AZD-9291 VX-11e MK-1775 Regorafenib (monohydrate) Empty
c Empty PND-1186 Cabozantinib PHA-680632 NVP-BHG712 AMG 900 TAK-733 KX2-391 (dihydrochloride) Tofacitinib (citrate) TAK-901 CZC-54252 Empty
d Empty GSK2126458 MLN 2480 PI-3065 PF-562271 AZD1152-HQPA JNK-IN-8 GSK-1070916 BLU9931 TG101209 Defactinib Empty
e Empty LY2090314 BMS 777607 SCIO-469 UNC2025 (hydrochloride) FRAX486 CCT196969 ZM-447439 GDC-0941 Enzastaurin TP-0903 Empty
f Empty MP7 Hesperadin CEP-32496 MGCD-265 analog ALK inhibitor 2 RAF265 Alisertib CH5424802 (Hydrochloride) Regorafenib (Hydrochloride) H-89 (dihydrochloride) Empty
g Empty Dabrafenib WYE-125132 GW 5074 BI 2536 Tauroursodeoxycholate (Sodium) PD173074 Dasatinib (hydrochloride) TG-101348 LOXO-101 (sulfate) SNS-314 Empty
h Empty KX2-391 (Mesylate) Doramapimod IPI549 ALK-IN-1 Nilotinib AST 487 Lck Inhibitor GDC-0068 (dihydrochloride) Cobimetinib NMS-1286937 Empty

Plate layout: HY-L009-9

1 2 3 4 5 6 7 8 9 10 11 12
a Empty GZD824 Ponatinib GSK1838705A CFI-400945 (free base) GNF-5837 Mps1-IN-1 BIBF 1120 XL-147 Saracatinib PLX8394 Empty
b Empty GSK461364 CNX-2006 Defactinib (hydrochloride) GNF-7 KU-60019 TAK-285 Pluripotin CCT 137690 NPS-1034 AKT inhibitor VIII Empty
c Empty LDN193189 (Hydrochloride) LY2801653 DDR1-IN-1 LEE011 (succinate) DCC-2036 Ro 31-8220 (mesylate) TAK-632 CO-1686 CGK733 Ningetinib Empty
d Empty Neratinib THZ531 LDK378 SU14813 (maleate) Canertinib (dihydrochloride) NVP-BGJ398 LDC1267 Entrectinib Quizartinib PD318088 Empty
e Empty BAY1217389 TAK-960 Flumatinib Tandutinib NVP-BSK805 (dihydrochloride) Cediranib (maleate) BMS-599626 (Hydrochloride) SU11274 WH-4-023 Motesanib (Diphosphate) Empty
f Empty GSK269962A LEE011 (succinate hydrate) LRRK2-IN-1 TGR-1202 Refametinib Palbociclib (isethionate) CHIR-99021 (trihydrochloride) Bafetinib Belizatinib CGI-1746 Empty
g Empty CEP-37440 ASP3026 Lapatinib Nilotinib (monohydrochloride monohydrate) Brigatinib Aurora A inhibitor I Imatinib (Mesylate) BX795 A 419259 (trihydrochloride) Masitinib (mesylate) Empty
h Empty AZD-9291 (mesylate) PI3K-IN-1 THZ1 (Hydrochloride) LY2835219 Avitinib (maleate) Torin 1 KRCA-0008 CYT387 (sulfate salt) EG00229 Neohesperidin dihydrochalcone Empty

Plate layout: HY-L009-10

1 2 3 4 5 6 7 8 9 10 11 12
a Empty LY2228820 NVP-TAE 684 Trametinib GNE-7915 (tosylate) Dabrafenib (Mesylate) LY-2584702 (tosylate salt) Volasertib LYN-1604 hydrochloride Ginsenoside Rh2 R788(prodrug of R406) Empty
b Empty R406 Sitravatinib LDK378 (dihydrochloride) Centrinone-B Foretinib Centrinone TAK-960 (dihydrochloride) FIIN-2 CEP-28122 (mesylate salt) Cabozantinib (S-malate) Empty
c Empty CO-1686 (hydrobromide) Sorafenib (Tosylate) XMD17-109 PHA-665752 BEZ235 (Tosylate) Cobimetinib (hemifumarate) BIBF 1120 (esylate) NVP-BGT226 CFI-400945 (fumarate) Flumatinib (mesylate) Empty
d Empty GDC-0853 PF-562271 (besylate) Icariin Trametinib (DMSO solvate) SCR-1481B1 GDC-0941 (dimethanesulfonate) Afatinib (dimaleate) KN-62 Ningetinib Tosylate R788 (disodium hexahydrate) Empty
e Empty Troxerutin Astragaloside IV GSK1904529A Lapatinib (ditosylate) Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Kinase Inhibitor Library
目录号:
HY-L009
需求量:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.